The Impact of Next-Generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Deep Penetrating Melanocytic Neoplasms.

Saved in:
Bibliographic Details
Title: The Impact of Next-Generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Deep Penetrating Melanocytic Neoplasms.
Authors: Jeyakumar JE; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Addo AK; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Beydoun HM; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Olivares S; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Bahrami A; Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA., Balamurugan T; Department of Pathology, Royal Surrey NHS Foundation Trust, Guildford, UK., Barnhill RL; Department of Translational Research, Institut Curie, Paris Sciences and Lettres Research University, and UFR of Medicine, University of Paris Cité, Paris, France., Blokx WAM; Department of Pathology, Division Laboratories, Pharmacy and Biomedical Genetics University Medical Center Utrecht, Utrecht, the Netherlands., Busam KJ; Department of Pathology, Dermatopathology Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA., Cerroni L; Department of Dermatology, Medical University of Graz, Graz, Austria., Cook M; Department of Pathology, Royal Surrey NHS Foundation Trust, Guildford, UK., de La Fouchardière A; Department of Biopathology, Centre Leon Bernard, Lyon, France., Duncan LM; Dermatopathology Unit, Pathology Service, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Elder DE; Department of Pathology and Laboratory Medicine, Division of Anatomic Pathology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ferguson P; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Department of Tissue and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia., Ferrara G; Anatomic Pathology and Cytopathology Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy., Johansson I; Department of Pathology, Institute of Biomedicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Ko JS; Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio, USA., Kwon JE; Department of Pathology, Ajou University School of Medicine, Suwon, South Korea., Landman G; Department of Pathology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Lezcano C; Department of Pathology, Dermatopathology Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA., Lowe L; Departments of Dermatology and Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA., Massi D; Department of Health Sciences, Section of Anatomic Pathology, University of Florence, Florence, Italy., Messina J; Departments of Pathology and Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Mihic-Probst D; Institute for Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Parker DC; Departments of Pathology and Dermatology, Emory University School of Medicine, Atlanta, Georgia, USA., Redpath M; Department of Pathology, McGill University, Quebec, Canada., Sargen MR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and NSW Health Pathology, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, the University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Shea CR; Department of Medicine, Section of Dermatology, University of Chicago, Chicago, Illinois, USA., Tetzlaff M; Dermatopathology and Oral Pathology Unit, Departments of Pathology and Dermatology, University of California, San Francisco, California, USA., Torres-Cabala C; Departments of Pathology and Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tron V; Lifelabs and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Xu X; Departments of Pathology and Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Yeh I; Departments of Dermatology and Pathology, University of California, San Francisco, California, USA., Yun SJ; Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea., Zembowicz A; Dermatopathology Consultations LLC, Lahey Clinic and Tufts Medical School, Boston, Massachusetts, USA., Gerami P; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Source: Journal of cutaneous pathology [J Cutan Pathol] 2026 Mar; Vol. 53 (3), pp. 293-301. Date of Electronic Publication: 2025 Dec 23.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0425124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0560 (Electronic) Linking ISSN: 03036987 NLM ISO Abbreviation: J Cutan Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1600-0560
DOI:10.1111/cup.70049